AU642632B2 - Purified hematoporphyrin dimers and trimers useful in photodynamic therapy - Google Patents

Purified hematoporphyrin dimers and trimers useful in photodynamic therapy Download PDF

Info

Publication number
AU642632B2
AU642632B2 AU38735/89A AU3873589A AU642632B2 AU 642632 B2 AU642632 B2 AU 642632B2 AU 38735/89 A AU38735/89 A AU 38735/89A AU 3873589 A AU3873589 A AU 3873589A AU 642632 B2 AU642632 B2 AU 642632B2
Authority
AU
Australia
Prior art keywords
document
compound
international
date
considered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU38735/89A
Other languages
English (en)
Other versions
AU3873589A (en
Inventor
Thomas John Dougherty
Ravindra K. Pandey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Health Research Inc
Original Assignee
Health Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Health Research Inc filed Critical Health Research Inc
Publication of AU3873589A publication Critical patent/AU3873589A/en
Application granted granted Critical
Publication of AU642632B2 publication Critical patent/AU642632B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
AU38735/89A 1988-07-06 1989-07-06 Purified hematoporphyrin dimers and trimers useful in photodynamic therapy Expired AU642632B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US21559288A 1988-07-06 1988-07-06
US215592 1988-07-06
US343865 1989-04-26
US07/343,865 US4968715A (en) 1988-07-06 1989-04-26 Use of purified hematoporphyrin trimers in photodynamic therapy

Publications (2)

Publication Number Publication Date
AU3873589A AU3873589A (en) 1990-02-05
AU642632B2 true AU642632B2 (en) 1993-10-28

Family

ID=26910191

Family Applications (1)

Application Number Title Priority Date Filing Date
AU38735/89A Expired AU642632B2 (en) 1988-07-06 1989-07-06 Purified hematoporphyrin dimers and trimers useful in photodynamic therapy

Country Status (7)

Country Link
US (1) US4968715A (fr)
EP (1) EP0423195B1 (fr)
JP (1) JPH089621B2 (fr)
AU (1) AU642632B2 (fr)
CA (1) CA1339367C (fr)
DE (1) DE68914457T2 (fr)
WO (1) WO1990000392A1 (fr)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE38994E1 (en) 1988-07-20 2006-02-28 Health Research, Inc. Pyropheophorbides conjugates and their use in photodynamic therapy
USRE39094E1 (en) 1988-07-20 2006-05-09 Health Research, Inc. Pyropheophorbides and their use in photodynamic therapy
US5059619A (en) * 1989-06-14 1991-10-22 Quadra Logic Technologies, Inc. Stable freeze-dried polyhematoporphyrin ether/ester
US5219878A (en) * 1990-10-05 1993-06-15 Queen's University Tetrapyrrole hydroxyalkylamide photochemotherapeutic agents
US5435307A (en) * 1991-03-29 1995-07-25 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Surface fluorescent monitor
PL165249B1 (pl) * 1991-10-29 1994-11-30 Wojskowa Akad Tech Sposób otrzymywania soli kompleksowych hematoporfiryny i jej pochodnych PL PL PL PL PL PL PL
US6551618B2 (en) 1994-03-15 2003-04-22 University Of Birmingham Compositions and methods for delivery of agents for neuronal regeneration and survival
US6103751A (en) * 1998-06-22 2000-08-15 Health Research, Inc. Carotene analogs of porphyrins, chlorins and bacteriochlorins as therapeutic and diagnostic agents
US20030215421A1 (en) * 1999-07-21 2003-11-20 Mcdonald John R. Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders
US7157418B1 (en) 1998-07-22 2007-01-02 Osprey Pharmaceuticals, Ltd. Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders
US7078014B2 (en) * 1999-12-23 2006-07-18 Health Research, Inc. Method for using chlorin and bacteriochlorin-based aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals
US7897140B2 (en) 1999-12-23 2011-03-01 Health Research, Inc. Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents
US7097826B2 (en) * 1999-12-23 2006-08-29 Health Research, Inc. Chlorin and bacteriochlorin-based difunctional aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals
US6534040B2 (en) 1999-12-23 2003-03-18 Health Research, Inc. Chlorin and bacteriochlorin-based aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals
US6624187B1 (en) 2000-06-12 2003-09-23 Health Research, Inc. Long wave length absorbing bacteriochlorin alkyl ether analogs
DE60328496D1 (en) 2002-06-27 2009-09-03 Health Research Inc Fluorinierte chlorin und bacteriochlorin photosensitizer für fotodynamische therapie
EP1606291A2 (fr) 2002-07-02 2005-12-21 Health Research, Inc. Synthese efficace de pyropheophorbide a et ses derives
US20050101582A1 (en) 2003-11-12 2005-05-12 Allergan, Inc. Compositions and methods for treating a posterior segment of an eye
US20070224278A1 (en) 2003-11-12 2007-09-27 Lyons Robert T Low immunogenicity corticosteroid compositions
JP2007518804A (ja) 2004-01-20 2007-07-12 アラーガン、インコーポレイテッド トリアムシノロンアセトニドおよびヒアルロン酸を好ましく含有する眼局所治療用組成物
US20050244500A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Intravitreal implants in conjuction with photodynamic therapy to improve vision
US20050244458A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Sustained release intraocular implants and methods for treating ocular neuropathies
US8722097B2 (en) 2004-04-30 2014-05-13 Allergan, Inc. Oil-in-water method for making polymeric implants containing a hypotensive lipid
US8119154B2 (en) 2004-04-30 2012-02-21 Allergan, Inc. Sustained release intraocular implants and related methods
US8591885B2 (en) 2004-04-30 2013-11-26 Allergan, Inc. Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems
WO2005107708A1 (fr) 2004-04-30 2005-11-17 Allergan, Inc. Implants d'inhibiteurs de tyrosine kinase intravitreens, biodegradables
US8425929B2 (en) 2004-04-30 2013-04-23 Allergan, Inc. Sustained release intraocular implants and methods for preventing retinal dysfunction
US7771742B2 (en) 2004-04-30 2010-08-10 Allergan, Inc. Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
US9498457B2 (en) 2004-04-30 2016-11-22 Allergan, Inc. Hypotensive prostamide-containing biodegradable intraocular implants and related implants
US8673341B2 (en) 2004-04-30 2014-03-18 Allergan, Inc. Intraocular pressure reduction with intracameral bimatoprost implants
US20050244465A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Drug delivery systems and methods for treatment of an eye
US7799336B2 (en) 2004-04-30 2010-09-21 Allergan, Inc. Hypotensive lipid-containing biodegradable intraocular implants and related methods
US20050244463A1 (en) 2004-04-30 2005-11-03 Allergan, Inc. Sustained release intraocular implants and methods for treating ocular vasculopathies
US8455656B2 (en) 2004-04-30 2013-06-04 Allergan, Inc. Kinase inhibitors
US8147865B2 (en) 2004-04-30 2012-04-03 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
US7993634B2 (en) 2004-04-30 2011-08-09 Allergan, Inc. Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
AU2005275220B2 (en) * 2004-07-16 2012-02-02 Health Research, Inc. Adduct of fluorescent dye and tumor avid tetrapyrrole
WO2006020979A2 (fr) * 2004-08-13 2006-02-23 Yale University Conjugues du facteur vii permettant de traiter selectivement des troubles de la neovascularisation
US20060198783A1 (en) * 2005-02-25 2006-09-07 Health Research, Inc., Roswell Park Cancer Institute Division Porphyrin-based compounds for tumor imaging and photodynamic therapy
WO2006095708A1 (fr) * 2005-03-08 2006-09-14 National University Corporation NARA Institute of Science and Technology Compose de porphyrine et son utilisation
WO2007023766A1 (fr) * 2005-08-23 2007-03-01 National University Corporation Gunma University Generateurs d'oxygene singulet avec substituants au silicium
US8969415B2 (en) 2006-12-01 2015-03-03 Allergan, Inc. Intraocular drug delivery systems
JP2010539163A (ja) * 2007-09-14 2010-12-16 ヘルス リサーチ インコーポレイテッド 腫瘍イメージング及び治療用のマルチモーダル剤
WO2011009020A2 (fr) 2009-07-16 2011-01-20 Mallinckrodt Inc. Composés et compositions pour une utilisation en photothérapie et dans le traitement d'une maladie néovasculaire oculaire et de cancers
CN102724951A (zh) 2009-11-09 2012-10-10 阿勒根公司 用于刺激毛发生长的组合物和方法
US8609837B2 (en) 2010-07-06 2013-12-17 Health Research, Inc. Metallation enhancements in tumor-imaging and PDT therapy
CN104379602B (zh) 2012-03-08 2017-05-03 哈洛齐梅公司 具有条件活性的抗表皮生长因子受体抗体及其使用方法
EP2956096A1 (fr) 2013-02-15 2015-12-23 Allergan, Inc. Implant à administration de médicament prolongée
EP3044236A2 (fr) 2013-09-12 2016-07-20 Halozyme, Inc. Anticorps anti-récepteur du facteur de croissance épidermique modifiés et procédés pour les utiliser
WO2017161206A1 (fr) 2016-03-16 2017-09-21 Halozyme, Inc. Conjugués contenant des anticorps à activité conditionnelle ou des fragments de liaison à un antigène associés, et procédés d'utilisation
CA3056396A1 (fr) 2017-03-14 2018-09-20 Ohio State Innovation Foundation Methodes et compositions se rapportant a des immunoconjugues igg3 ciblant le facteur tissulaire
EP3724225A1 (fr) 2017-12-15 2020-10-21 Juno Therapeutics, Inc. Molécules de liaison à l'anti-cct5 et procédés d'utilisation associés
CN108440644B (zh) * 2018-03-22 2021-04-02 哈尔滨工业大学 一种高水溶性的卟啉二聚物及其应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4649151A (en) * 1982-09-27 1987-03-10 Health Research, Inc. Drugs comprising porphyrins
AU3971489A (en) * 1988-07-20 1990-02-19 Health Research Inc. New photosensitizing agents
AU4663589A (en) * 1988-12-08 1990-06-26 Luminis Pty Limited Porphyrin compounds and their uses

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4649151A (en) * 1982-09-27 1987-03-10 Health Research, Inc. Drugs comprising porphyrins
AU3971489A (en) * 1988-07-20 1990-02-19 Health Research Inc. New photosensitizing agents
AU4663589A (en) * 1988-12-08 1990-06-26 Luminis Pty Limited Porphyrin compounds and their uses

Also Published As

Publication number Publication date
JPH089621B2 (ja) 1996-01-31
AU3873589A (en) 1990-02-05
DE68914457T2 (de) 1994-07-21
DE68914457D1 (de) 1994-05-11
US4968715A (en) 1990-11-06
JPH04500953A (ja) 1992-02-20
WO1990000392A1 (fr) 1990-01-25
CA1339367C (fr) 1997-08-26
EP0423195A4 (en) 1992-02-26
EP0423195A1 (fr) 1991-04-24
EP0423195B1 (fr) 1994-04-06

Similar Documents

Publication Publication Date Title
AU642632B2 (en) Purified hematoporphyrin dimers and trimers useful in photodynamic therapy
US5190966A (en) Purified hematoporphyrin dimers and trimers useful in photodynamic therapy
US5314905A (en) Pyropheophorbides conjugates and their use in photodynamic therapy
US5198460A (en) Pyropheophorbides and their use in photodynamic therapy
US5093349A (en) Photosensitizing agents
US5095030A (en) Wavelength-specific cytotoxic agents
AU683856B2 (en) Wavelength-specific photosensitive porphacyanine and expanded porphyrin-like compounds and methods for preparation and use thereof
US5308608A (en) Photosensitizing Diels-Alder porphyrin derivatives
US5149708A (en) Photosensitizing Diels-Alder porphyrin derivatives
KR100358273B1 (ko) 광감작제
US4961920A (en) Phototherapeutic monovinyl and divinyl ether-linked dimers
USRE38994E1 (en) Pyropheophorbides conjugates and their use in photodynamic therapy
USRE39094E1 (en) Pyropheophorbides and their use in photodynamic therapy
AU641658B2 (en) Photosensitizing diels-alder porphyrin derivatives
AU669876C (en) Pyropheophorbides and their use in photodynamic therapy